🔎 Trials Near Me

Beranda › Melanoma › Utah

Uji klinis Melanoma di Utah

26 studi untuk Melanoma mencari peserta di lokasi di Utah.

Kota di Utah

Teks studi resmi (Bahasa Inggris)

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • START Mountain Region, West Valley City
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06270706

Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma

  • Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06365619

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05136196

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

  • University of Utah Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

  • Intermountain Health, Salt Lake City
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT05727904

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

  • Primary Children's Hospital, Salt Lake City
Menerima pesertaFase 2
Hingga usia 25 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07621614

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

  • University of Utah - Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05267626

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04511013

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • Utah Cancer Specialists, Salt Lake City
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT05059444

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

  • START Mountain Region, West Valley City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07287917

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT05896839

Project: Every Child for Younger Patients With Cancer

  • Primary Children's Hospital, Salt Lake City
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244

A Study of MGC026 in Participants With Advanced Solid Tumors

  • START Mountain Region, West Valley City
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06242470

A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors

  • START Mountain Region, West Valley City
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06880549

Rural Adult and Youth Sun Protection Study

  • University of Utah, Salt Lake City
Menerima pesertaSukarelawan sehat diterima
Usia 3 hingga 7 · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06439979

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Agu 2026 · NCT06330064

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

  • Huntsman Cancer Institute at The University of Utah, Salt Lake City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT07556380

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

  • Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT05379985

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

  • University of Utah Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Feb 2026 · NCT05549297

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

  • Huntsman Cancer Institute, University of Utah 2000 Circle of Hope, Salt Lake City, UT
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Des 2025 · NCT03567889

Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

  • Huntsman Cancer Institute, Salt Lake City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2025 · NCT06194929

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

  • Huntsman Cancer Institute - University of Utah, Salt Lake City
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Okt 2025 · NCT06249048

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Salt Lake City
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

  • Intermountain Medical Center, Murray
  • Huntsman Cancer Institute (The University of Utah), Salt Lake City
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883

Dari ClinicalTrials.gov, data diambil 4 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.